Home » Newsletters » BioWorld Science

BioWorld Science

June 12, 1997

View Archived Issues

Clinical results in NIDDM reported for troglitazone

Pioglitazone improves insulin resistance in NIDDM

New preclinical studies on JTT-501

Phase III results for AY-4166

Clinical safety and efficacy of TS-110 for inflammation and pain

Carbovir not associated with mitochondrial toxicity in intact cells

BRL-48482 has potential for reducing cardiovascular risk in NIDDM

Paracelsian cancels launch of AndroVir

Novel site of action for chimeric insulin-releasing peptide

Otsuka AGE inhibitor prevents progression of diabetic nephropathy in animal model

Novopharm Biotech files Canadian IND for hMAb

Promising preliminary results with Oncor's HER-2/neu in prostate trial

M-16049: hypoglycemic agent and aldose reductase inhibitor

Mylan files ANDA for generic nifedipine

MedImmune: Q1 1997 highlights

Cambridge Antibody Technology: Six-month results and highlights

Ergoset clinical study results presented at diabetes congress

A wealth of clinical data on pramlintide presented at diabetes congress

FDA clears Hemagen Diagnostics' test for connective tissue diseases

Arris and Abbott sign licensing agreement

Harvard Medical School and Hoechst Marion Roussel enter research agreement

Alfa Wassermann and Merckle sign development and marketing agreement for rifaximin

Paracelsian cancels launch of AndroCar

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...